📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera. (2023)

First Author: Sørensen CV

Attributed to: MICA: Combinational therapeutic approaches using regenerative medicine and next generation antivenoms to prevent/treat snakebite-induced muscle damage funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.toxicon.2023.107307

PubMed Identifier: 37783315

Publication URI: http://europepmc.org/abstract/MED/37783315

Type: Journal Article/Review

Volume: 234

Parent Publication: Toxicon : official journal of the International Society on Toxinology

ISSN: 0041-0101